June 2022 FDA Recall Draximage Maa by Jubilant Draximage Inc
D-1189-2022 - Lack of Assurance of Sterility
This Class II drug recall was voluntarily initiated by Jubilant Draximage Inc on June 16, 2022 for the product Draximage Maa. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1189-2022
Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.
06-16-2022
07-20-2022
519 cartons/30 vials each
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Jubilant Draximage Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Product was distributed to retailers nationwide.
07-25-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.
Batch or Lot Expiration Information
Lot# 1H005, exp. date Nov 30, 2023